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Abstract Lumbar interlaminar and transforaminal epi-
dural injections are used in the treatment of lumbar
radicular pain and other lumbar spinal pain syndromes.
Complications from these procedures arise from needle
placement and the administration of medication. Potential
risks include infection, hematoma, intravascular injection
of medication, direct nerve trauma, subdural injection of
medication, air embolism, disc entry, urinary retention,
radiation exposure, and hypersensitivity reactions. The
objective of this article is to review the complications of
lumbar interlaminar and transforaminal epidural injections
and discuss the potential pitfalls related to these proce-
dures. We performed a comprehensive literature review
through a Medline search for relevant case reports, clinical
trials, and review articles. Complications from lumbar
epidural injections are extremely rare. Most if not all
complications can be avoided by careful technique with
accurate needle placement, sterile precautions, and a
thorough understanding of the relevant anatomy and con-
trast patterns on ﬂuoroscopic imaging.
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Introduction
Lumbar epidural steroid injections have been used in the
treatment of lumbar radicular pain and other spinal pain
syndromes [1–4]. The goal is to deliver steroids and anes-
thetics into the epidural space around the spinal nerves and
other spinal structures. By deﬁnition, an interlaminar injec-
tionisanapproachtothedorsalepiduralspacegoingthrough
the space between the lamina of the vertebrae. A transfora-
minal injection is an approach toward the epidural space via
the intervertebral foramen where the spinal nerves exit.
The epidural space surrounds the dural sac and is
bounded by the posterior longitudinal ligament anteriorly,
the ligamentum ﬂavum and the periosteum of the laminae
posteriorly, and the pedicles of the spinal column and the
intervertebral foramina containing their neural elements
laterally. The space communicates freely with the para-
vertebral space through the intervertebral foramina. The
epidural space contains loose areolar connective tissue,
semi-liquid fat, lymphatics, arteries, an extensive plexus of
veins, and the spinal nerve roots as they exit the dural sac
and pass through the intervertebral foramina [5–7].
The anatomy of the lumbar intervertebral foramen is
complicated. It is formed by the pedicles of adjacent ver-
tebrae above and below, the vertebral body of the superior
and inferior vertebrae (mostly of the superior vertebra) and
intervertebral disc anteriorly, and the articular processes
forming the zygapophyseal joint posteriorly. The fascia and
psoas muscle form the lateral border, while the medial
border contains the dural sleeve [8, 9]. The foramen allows
for the passage of the spinal nerve, the dorsal root ganglion,
the segmental spinal artery, the communicating veins
between the internal and external plexuses, the recurrent
meningeal (sinu-vertebral) nerves, and the transforaminal
ligaments [8, 9].
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and based on the embryological development of the body
[10, 11]. An ‘‘outside in’’ simpliﬁed algorithm can best
describe it: aorta ? segmental artery (31 pairs (8 cervical,
12 thoracic, 5 lumbar, 5 sacral, 1 coccygeal)) ? radicular
artery (supplies dorsal and ventral nerve roots) ? radicu-
lopial artery or radiculomedullary ? posterior (paired) or
anterior (single) spinal artery [10, 11]. At the start of
embryological development, each segmental artery has a
branch that supplies the spinal cord. During development
most of these branches regress leaving a few left behind to
provide blood for the spinal cord. Of those that remain 4–8
will supply the anterior spinal artery and 10–20 will supply
the posterior spinal arteries [10, 11]. The radiculopial
artery branches into the posterior spinal arteries. The rad-
iculomedullary artery branches into the anterior spinal
artery. Of particular interest is the artery of Adamkiewicz,
which is the largest radiculomedullary artery and major
supplier of the anterior spinal artery in the lumbar region.
The artery enters the spinal canal through a single inter-
vertebral foramen in 85% of individuals between T9 and
L2 [12, 13] and is located 63% of the time on the left side
[14]. Its origin is highly variable [15] and in a minority of
people may arise from the lower vertebrae in the lumbar
spine [16] and rarely as low as S1.
To reach the optimal target area for an interlaminar
epidural steroid injection (ILESI), a paramedian or midline
approach is used through the space between the lamina of
the vertebrae. The needle ﬁrst penetrates the skin, then
subcutaneous tissue, paraspinal muscles, and then ﬁnally
the ligamentum ﬂavum. The ‘‘loss of resistance’’ technique
is used to verify penetration into the dorsal epidural space
[17].
With an oblique needle approach, the optimal target area
for the transforaminal epidural steroid injection (TFESI) is
classically described on the posterior surface of the verte-
bral body, adjacent to the caudal border of the pedicle
above the target nerve, opposite the sagittal bisector of the
pedicle, also known as the ‘‘6 o’clock’’ position [18]
(Figs. 1 and 2). With the more commonly described sub-
pedicular approach, the target point lies within the
imaginary ‘‘safe triangle’’ which is formed by the trans-
verse line tangential to the lower margin of the pedicle, a
sagittal line tangential to the lateral margin of the pedicle,
and a hypotenuse passing obliquely inferiorly and laterally
from the inferior medial corner of the pedicle, tangential to
the curvature of the pedicle at that corner [18] (Fig. 5b).
Two alternative approaches for TFESI include the ret-
roneural approach and the retrodical approach. The
retroneural TFESI approach describes the optimal target
area more dorsal in the intervetebral foramen compared to
the subpedicular technique [18]. The target typically lies at
the intersection of two lines: a longitudinal one between the
posterior and middle third of the intervertebral foramen,
and a transverse one between the upper and middle third of
the intervertebral foramen [18] (Figs. 1 and 2). The retro-
discal TFESI approach places the needle past the lateral
surface of the superior articular process (SAP) into the
intervertebral foramen; this technique is similar to the
needle approach used in discography, but without cannu-
ating the disc [19] (Figs. 1 and 2). In this latter technique,
the exiting spinal nerve is lateral rather than medial to the
needle as in the subpedicular and retroneural techniques.
The incidence of complications described in the litera-
ture with these epidural techniques is low [20, 21]. A
thorough understanding of the relevant anatomy and
potential pitfalls is necessary to avoid most if not all
complications. Complications are related either to the
procedure itself—mostly inadvertent placement of the
needle off target—or the administration of the corticoste-
roid or local anesthetic. The purpose of this paper is to
review these complications and discuss the potential pit-
falls related to these procedures.
Complications
Infections
Infections have been reported to occur in 1–2% of spinal
injections [22]. Severe infections are noted to be rare with
an incidence of 0.1–0.01% of all spinal injections [22].
They vary between meningitis [23, 24], epidural abscess
[23, 25, 26], osteomyelitis [27, 28], and discitis [29].
Staphylococcus aureus is the most common organism
reported to be found. It is believed to be introduced via the
skin through needle puncture. It is usually introduced due
to poor sterile technique. Undetected and untreated infec-
tion can lead to sepsis and spread to other sites through
direct contiguous spread or through Batson’s plexus [22].
Neurological deﬁcits can occur due to compression from
exudate [30]. Patients with immunocompromising condi-
tions such as diabetes are more susceptible to infection and
should be followed closely [30].
Infection from gram-negative anaerobes can theoreti-
cally occur by unintentional penetration into the intestinal
or pelvic cavity [22]. This is particularly easy to do in S1
TFESIs. The needle can unintentionally go through the
dorsal foramen and past the ventral foramen entering the
pelvic cavity (Fig. 3). In Fig. 3a, the needle is placed using
‘‘tunnel vision’’ into the S1 dorsal foramen. With this
technique there may be a lack of bony structure to stop
needle advancement. Lateral imaging (Fig. 3b) is critical to
check needle depth as it is relatively easy to advance past
the ventral foramen and into the pelvic cavity. If this
should occur, i.e., the needle depth is miscalculated prior to
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needle completely and discarding it from the sterile ﬁeld
rather than repositioning the needle more posteriorly.
In the other lumbar TFESIs there is potential to go past
the foramen, along the lateral border of the vertebral body,
and into the abdominal cavity potentially piercing the
intestinal cavity. At times in the subpedicular or retroneural
approaches the SAP obstructs the path to the ‘‘6 o’clock’’
position on the pedicle. The needle is advanced laterally to
avoid the SAP. If advanced too far lateral the needle tip can
end up along the lateral aspect of the vertebral body instead
of more medial into the intervertebral foramen. Lateral
imaging helps to further conﬁrm the depth of the needle. If
the needle depth goes past the anterior border of the ver-
tebral body, it can potentially pierce the intestinal cavity.
In the primary author’s experience, this rarely occurs.
However; one must be alerted to this possibility. Once
again, if the needle happened to be too far anterior, we
recommend discarding the needle rather than repositioning
more posterior and medially to minimize the chance of
introducing iatrogenic infection.
Hematomas
Piercing a vessel is an inherent risk to all injection proce-
dures. Potential complications associated with this are
bleeding, the formation of hematomas, and intravascular
injection of medication. The potential for bleeding and
hematoma formation is increased in patients with a coagu-
lopathy, liver disease, or in patients that take anticoagulant
Fig. 1 Fluoroscopic images of the target points for a left L4 TFESI.
The brown circle marks the target point for the subpedicular
approach, the blue circle for the retroneural approach, and the pink
circle for the retrodiscal approach. a AP view. The subpedicular and
retroneural approaches have the same target point on AP view. It
lies at the bottom of the silhouette of the L4 pedicle (P), but is
overlapped by the lateral margin of the L4 lamina [18]. The
retrodiscal approach target is lateral to the L5 superior articular
process (black arrow) which is not clearly seen on AP imaging.
b Left oblique view. The lamina has been rotated medially to
expose the target points for all three approaches. The subpedicular
and retroneural approaches have the same target point on oblique
view. The retrodiscal target point is more easily identiﬁed on
oblique view (black arrow). c Lateral view. The subpedicular
approach target area lies on the back of the L4 vertebral body. The
retroneural approach target area lies more dorsal in the L4–L5
foramen underneath the L4 pedicle (P). The retrodiscal approach
target area lies just dorsal to the L4–L5 disc space
214 Curr Rev Musculoskelet Med (2008) 1:212–222medications such as warfarin or clopidogrel [22, 31]. Dam-
age to the underlying vessels may lead to hematomas that
cannot be visualized under traditional ﬂuoroscopy.
Patients use chronic anticoagulant therapy for the preven-
tion of myocardial ischemia or stroke, thromboprophylaxis
after surgery, or treatment of acute thromboembolism [32].
Theintensityanddurationofanticoagulationaffecttheriskof
spontaneous, as well as procedural-related spinal bleeding
[32, 33]. This risk is increased signiﬁcantly with the use of
multipleanticoagulants[32,33].Thefollowingguidelinesfor
performing spinal procedures in anticoagulated patients are
basedonthesecondAmericanSocietyofRegionalAnesthesia
and Pain Medicine (ASRA) Consensus Conference on Neur-
axial Anesthesia and Anticoagulation in 2003 [32, 34].
Warfarin therapy should be discontinued 4–5 days before
spinalproceduresandtheinternationalnormalizedratio(INR)
should be within normal range at the time of the procedure to
ensureadequatelevelsofallvitaminK-dependentfactors[32,
34].Thienopyridinederivatives,e.g.,clopidogrel,ticlopidine,
shouldbesuspended7 daysand14 days,respectively,priorto
spinal procedures to allow for recovery of primary and sec-
ondary platelet aggregation and platelet–ﬁbrinogen binding
[32, 34]. Aspirin and non-steroidal antiinﬂammatory drugs
(NSAIDs) have not been found to have any contraindications
for spinal procedures [32, 34, 35]. Low-molecular weight
heparin (LMWH) should be held for at least 12 h before the
procedure in thromboprophylactic dosing and at least 24 h in
therapeutic dosing [32, 34].
Theincidenceofepiduralhematomaisapproximatedtobe
less than 1 in 150,000 epidurals [34]. The actual incidence of
neurologic dysfunction resulting from hemorrhagic compli-
cations is unknown [34]. Epidural hematomas can lead to
compressionofthespinalnerveornervescausingirreversible
damage [36]. Nerve injury may be minimized by evacuation
ofthehematomawithin24 hoftheﬁrstsymptoms[37].Inthe
lead author’s experience, an epidural hematoma was inci-
dentally discovered while performing an ILESI (Fig. 4). The
patient had a myelogram 2 weeks prior to the epidural injec-
tion at a different facility, which presumably led to the
unrecognized epidural hematoma. During the ILESI the nee-
dle was unintentionally placed in the superior aspect of the
hematoma. Upon injection of contrast, an unusual dye spread
occurred. Because the pattern of spread could not be deﬁni-
tively distinguished, the ILESI was aborted and a TFESI was
Fig. 2 Model images of needle placement for a left L4 TFESI. The
brown needle illustrates the subpedicular approach, the blue needle
shows the retroneural approach, and the pink needle depicts the
retrodiscal approach. a AP view. The subpedicular and retroneural
approaches have the same target point at the ‘‘6 o’clock’’ position of
the L4 pedicle (P). The retrodiscal approach target is lateral to the
L5 superior articular process (SAP). b Left oblique view. The
subpedicular and retroneural approach have the same target point at
the ‘‘6 o’clock’’ position of the L4 pedicle (P). The retrodiscal
approach target is lateral to the L5 SAP (overlapped by the brown
needle). TP = transverse process. c Lateral view. The subpedicular
approach target area lies on the back of the L4 vertebral body. The
retroneural approach target area lies more dorsal in the L4–L5
foramen underneath the L4 pedicle (P). The retrodiscal approach
target area lies just dorsal to the L4–L5 disc. TP = transverse
process
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(MRI) of the lumbar spine was obtained demonstrating the
epidural hematoma. The contrast spread, in essence, is an
epidural hematogram. Fortunately, images were saved docu-
menting that the hematoma must have existed prior to the
epiduralinjectionratherthanbecauseoftheepiduralinjection.
Additionally, by not injecting further, the ILESI did not
increase volume to the mass.
Intravascular injections
Recognition of intravascular uptake and contrast spread is
needed to avoid inadvertent injection of medications into
the vascularity. Furman et al. [38] reported an overall rate
of 11.2% for intravascular injection for lumbosacral
TFESIs. TFESIs at the S1 level had an intravascular
injection rate of 21.3%, compared with 8.1% for all lumbar
injections. With ILESIs, intravascular uptake is more
common with needle placement in the lateral portion of the
spinal canal than midline because the internal posterior
vertebral venous plexus within the epidural space is located
predominantly dorsolaterally [39]. The incidence of intra-
vascular uptake with ILESI is reported by Sullivan et al.
[40] to be 1.9%. Using a blood ‘‘ﬂash back’’ or blood
aspiration to predict an intravascular injection was not
reliable. It is postulated that there is not enough pressure in
the venous system to result in spontaneous blood ﬂow into
the needle hub. However, during contrast or medication
injection, there is enough positive pressure to keep these
smaller vessels distended, resulting in intravascular injec-
tion [38, 40, 41]. Therefore contrast injection is essential to
minimize subsequent intravascular injection of medications
[38]. Intravascular uptake is twice as likely to occur in
patients over 50 years of age [40].
In the studies that reported the incidence of intravascular
injections, no complications or adverse affects were found
from intravascular, presumably intravenous, injection of
contrast, steroid, or local anesthetic. [38, 40, 41]. Theo-
retically, patients may experience temporary adverse
reactions from systemic uptake of local anesthetics. These
symptoms include a range of minor symptoms: dizziness,
tinnitus, disorientation, muscle twitching, and metallic
taste to major symptoms: seizures, unconsciousness, and
coma. The severity of symptoms depends on the amount of
Fig. 4 Interlaminar epidural depicting epidural hematomagram
(white arrows). Black arrow placed to highlight needle location
Fig. 3 a AP image of needle in the right S1 foramen (white circle)
of a cadaveric specimen. White arrow shows needle tip. b Lateral
image depicting the needle penetrating into the pelvic cavity
through the S1 ventral foramen. Green line delineating the dorsal
sacral border. Red line delineating the ventral sacral border. White
arrow illustrating the tip of the needle in the pelvic cavity of a
cadaveric specimen
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tions may also diminish the efﬁcacy of epidural injections
[38]. For example, when performing medial branch blocks,
Dreyfuss found a 50% false negative rate with intravas-
cular uptake even when the needle was repositioned such
that intravascular uptake was eliminated [43].
While intravenous penetration is relatively common
with minimal sequelae, intraarterial penetration and sub-
sequent injection of particulate steroids can lead to a
catastrophic outcome. This occurs via the artery of Ad-
amkiewicz which travels with the nerve root through the
neural foramen and supplies the anterior spinal artery. This
can lead to a spinal infarction and paraplegia [12, 13, 44].
Use of contrast before injection helps to avoid this com-
plication by being able to distinguish an epidural spread
versus an intravascular spread. Since the artery enters the
spinal canal 85% of the time between T9 and L2 [12, 13]
and is located on the left side 63% of the time [14],
heightened precaution should be taken for TFESIs at these
levels. Houten et al. [12] reported on three cases of para-
plegia after lumbosacral nerve block believed to be the
result of inadvertent intraarterial injection and an unusually
low origin of the artery of Adamkiewicz. In each instance,
penetration of the vessel was undetected, i.e., no blood
ﬂashes back. In two procedures the needles were placed
transforaminally, one at L3–4 on the left and one at L3–4
on the right, and in the third the tip of the needle was
placed immediately lateral to the S1 nerve root [12].
Some injectionists utilize digital subtraction angiography
(DSA) to help distinguish intraarterial injection of contrast
and thus avoid further injection of local anesthetic or steroids
into the arterial system. DSA is a computer-assisted X-ray
techniquethatseparatesandremovesimagesofboneandsoft
tissue to permit visualization of vascular structures. DSA,
however, is not routinely available in most facilities. In our
practice, we utilize dexamethasone sodium phosphate for all
TFESIs. There has yet to be any reported complications with
thispreparation.This maybedue toits non-particulate nature
[45]. Derby et al. [45] found that dexamethasone sodium
phosphateparticlesizeisapproximately10timessmallerthan
red blood cells, the particles do not appear to aggregate, and
they have the lowest density compared to other commonly
used steroid preparations (e.g., triamcinolone acetonide,
methylprednisolone acetate, betamethasone sodium phos-
phate, and betamethasone acetate). Theoretically, these
attributes should lower the risk of embolic infarcts or prevent
them from occurring after intraarterial injection [45]. There
maybeatradeoffintheefﬁcacyofthisnon-particulatesteroid
in that it has a shorter duration of action. Dreyfuss et al. [46]
reportedthatthe effectiveness ofdexamethasone was slightly
less than that of triamcinolone, but the difference was neither
statistically nor clinically signiﬁcant. Since particulate ste-
roidshavebeenassociatedwithspinalcordinfarctions[12,44,
47],perhapsasaferyetlessefﬁcaciousnon-particulatesteroid
should be used [46].
In the primary author’s experience, there is a theoretical
advantage to the retroneural and retrodiscal techniques in
TFESIs in terms of vascular anatomy. Since the optimal
target area places the tip of the needle more dorsal in the
intervertebral foramen, there is less risk of pinning a spinal
artery against the posterior wall of the vertebral body or
injecting into it.
Nerve trauma
Direct trauma to a spinal nerve or dorsal root ganglion by a
needle is another complication of inadvertent needle
placement, especially when performing TFESIs. Severe
pain is caused with this trauma so it is important not to over
sedate the patient so that this complication is not masked. If
severe pain accompanies needle placement, then the needle
should be slightly withdrawn and its position reassessed
[18]. In the ﬁrst author’s experience, injecting a small
volume of local anesthetic while repositioning the needle
Fig. 5 a Right oblique image
with attention to the L4/L5
interspace after classic
subpedicular TFESIs. (Needles
placed underneath the right L3,
L4, L5, and S1 pedicles). Black
arrow highlighting exiting right
L4 spinal nerve. b Same image.
White triangle illustrating ‘‘safe
triangle’’ target area for
subpedicular and retroneural
approaches for TFESI. Black
triangle illustrating target area
for retrodiscal approach for
TFESI
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should be used such that the anesthetic is not forcibly
injected. Furthermore, staying more posterior in the fora-
men, i.e., the retroneural approach may help avoid nerve
trauma. The retrodiscal approach may also reduce the
incidence of nerve trauma relative to the classic subpe-
dicular approach in that the nerve may rest further from the
target point (Fig. 5). The drawback to the retrodiscal
approach may be a less recognizable epidural spread of
contrast compared to the other classic approaches. These
phenomena, to our knowledge, have not been formally
reported or studied.
Dural puncture
InadvertentspinalduralpunctureduringILESIsand TFESIs
with subsequent entry into the subdural and subarachnoid
space can also occur. Dural puncture can occur with ILESIs
when the needle is advanced beyond the dorsal epidural
space, thereby entering the central spinal canal. Dural
puncturehasalso been reported with TFESIsvia penetration
of the dural sleeve that surrounds the exiting spinal nerves
[48]. Cerebral spinal ﬂuid (CSF) ﬂashback is typically used
to recognize the complication of a dural puncture. Recog-
nition of epidural contrast spread versus subdural and
subarachnoid contrast spread patterns is essential because
duralpenetrationmaynotbeaccompaniedbyCSFﬂashback.
This is especially true when performing TFESIs [48].
Figure 6 illustrates dural puncture during a TFESI with sub-
duralspreadofcontrastinapreviouslyreportedcasestudy[48].
If local anesthetics are injected intrathecally, blockade
of neural elements can result in central canal, cauda equina,
and conus medularis syndromes depending on the level of
penetration and blockade. Other reported complications
with intrathecal injections of medications include persis-
tent parathesias, arachnoiditis, and meningitis. Temporary
respiratory depression, ascending weakness/sensory loss,
apnea, and unconsciousness may also occur and are felt to
be related to ascending subdural spread of anesthetics [26,
48–52]. The amount of local anesthetic typically used in
lumbar epidurals (6–8 ml) usually is not sufﬁcient enough
to cause respiratory depression. However, a larger volume
within the subdural space can ascend rapidly in a cephalad
direction causing serious cardiovascular and respiratory
effects [48, 53, 54]. Chauhan et al. [53] describe a case of
unintentional combined epidural and subdural block while
attempting to perform an epidural block for transurethral
resection of the prostate. A 20 ml injection of 1.5% lido-
caine and 0.5% bupivacaine resulted in aphonia and
respiratory paralysis requiring endotracheal intubation and
controlled ventilation for 3 h. The potential for such seri-
ous complications heightens the operator’s need to
recognize both subarachnoid and subdural contrast spread
patterns.
Dural punctures may also lead to spinal headache. These
headaches are typically severe, dull, non-throbbing pain,
and fronto-occipital in location, that aggravate in the
upright position and diminish in the supine position. CSF
can leak through the dural puncture leading to a loss of
CSF pressure and a drop in brain volume. The mechanism
producing the headache is unclear, though two theories do
exist. First, in an upright position there is tension on the
Fig. 6 a AP scout image of right L3 transforaminal needle
placement. Right L4 and right L5 transforaminal epiduragrams are
illustrated (white arrows) [43]. b Subdural injection of contrast at L3
(white arrows) [43]
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nociceptors causing pain [55]. Secondly, it is thought that
in the upright position more CSF is forced to exit the dural
puncture and the body compensates by venodilation caus-
ing pain related to vascular distension [55].
Air embolism
When using air with the ‘‘loss of resistance’’ technique in
ILESI to identify the epidural space, there are risks with
injecting too much air. One possibility is placing the needle
both epidurally and intravascularly without a blood ﬂash
back. A subsequent injection of air can then cause an air
embolism to develop within the vasculature. MacLean and
Bachman [56] depicted a case of syncope, arrhythmia, car-
diac ischemia, and neurologic deﬁcit after a spinal epidural
injectionwhich causedanarterial gasembolus.There isalso
the possibility of injecting excessive air epidurally to mimic
a mass lesion. Ammirati and Perino [57] documented a case
ofnewneurologicalsymptomsoccurringimmediatelyaftera
lumbarepidural.AnMRIrevealed trapped airdisplacing the
duralsac.Attentionshouldbepaidtotheamountofairbeing
injected during epidurals to limit this problem.
Disc entry
ILESI and TFESI can also spread medications to structures
outside of the intended epidural target, especially with
aberrant or pathological anatomy. Finn and Case [58], for
example, recounted a case of disc entry as a complication
of transforaminal injection. Though this occurrence is rare,
we do not consider this a complication because anecdotally
we have found excellent outcomes with injecting around
the spinal nerve and into the disc herniation simulta-
neously. Figure 7 illustrates intradiscal spread of contrast
and subsequent medications with a TFESI.
Bladder complications
Urinary complications occur more commonly in elderly
males, multiparous females, and patients who had inguinal
and perineal surgery [22]. The administration of local
anesthetics around the lumbar and sacral nerve roots has a
higher incidence of urinary retention [59]. Epidural block
of S2–S4 root ﬁbers decreases urinary bladder tone and
inhibits the voiding reﬂex [60].
Radiation exposure
The risk of ﬂuoroscopic exposure to the patient is minimal
for one or several isolated ﬂuoroscopic guided epidurals
[22]. A properly calibrated digital ﬂuoroscopy machine
delivers a low dose of ionizing radiation. It is the
cumulative exposure to the physician, nurses, radiology
technicians, and anyone else that is routinely involved in
these procedures that are at risk for complications [61–63].
Possible complications are cancer, sterility, cataract devel-
opment, bone marrow suppression, and skin desquamation.
The annualmaximum target area/organ permissible radiation
doses are as follows: thyroid 50 rem (roentgen equivalent in
man), extremities 50 rem, lens of the eye 15 rem, gonads
50 rem, whole body 5 rem [64]. Manchikanti et al. docu-
mented the radiation exposure to clinicians after ﬂuoroscopic
interventional spinal procedures in 1,000 consecutive patients.
The radiation exposure to the physician on the outside of the
lead apron over the upper chest was 1,345 mrem for the
entire period. Exposure for 2,000 procedures extrapolated to
2,690 mrem outside the apron which is within the annual
limits of exposure [63].
There are many ways to limit the amount of exposure to
the patient, physician, and staff. The National Council on
Radiation and Measurements (NCRP) endorse the concept
of ALARA (as low as reasonably achievable), which is
based on the premise that all radiation exposures that can
be prevented should be prevented [64]. Fishman et al. [65]
described three major ways to reduce clinician radiation
exposure: (1) maximize the distance from the radiation
source, (2) minimize the time of radiation, (3) use protec-
tive shielding devices.
Radiation dissipates at the inverse square of the distance
from the ﬂuoroscopy tube. Therefore, standing six feet or
Fig. 7 AP image of a left L5 transforaminal sequestered disc
injection. Contrast spread along the left L5 spinal nerve (white
arrow) and into the L5/S1 disc space (black arrow). Red arrow
depicting needle tip placement
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The ﬂuoroscopy anode should be kept under the procedure
table thus the patient absorbs the bulk of the directed
radiation [63, 65]. Intermittent ﬂuoroscopy, last image
hold, and pulsed ﬂuoroscopy are ways to reduce radiation
times [66]. In the lead author’s experience, good technique
and a clear understanding of the relevant anatomy and
contrast patterns also minimizes radiation exposure by
reducing the time to set up the images and perform the
injections. According to Fishman, Manchikanti, et al. [63,
65], all staff in the procedure room should at least wear a
lead apron and thyroid shield to decrease radiation expo-
sure. Radiation dosimetry badges should be worn to
monitor exposure [63, 65]. Manchikanti et al. showed that
in 1,000 consecutive procedures the radiation exposure
inside the thyroid shield and lead apron was 0 mrem.
Medication complications
Medication complications are rare with the drugs used in
lumbar spinal injections. The most common local anesthetics
used are lidocaine and bupivacaine. Their primary route of
actionisreversiblyblockingthesodiumchannelsinnerveand
muscle membranes [67]. Although very uncommon, physi-
cians must be aware of possible allergy to local anesthetic or
its preservative, which occurs within 2 h after epidural
injectionbuthasbeenknowntohappenupto6 hlater[68,69].
Inadvertent intrathecal injection of local anesthetic can result
in spinal anesthesia as previously addressed.
Corticosteroids inherently have side effects: dizziness,
headache, facial erythema, transient hypotension and
hypertension, gastritis, mood swings, pruritus, insomnia,
and menstrual irregularities [70]. Prolonged therapy with
corticosteroids may result in suppression of the hypothal-
amus–pituitary–adrenal (HPA) axis by inhibiting
adrenocorticotropic hormone (ACTH) [70]. Rarely can a
Cushingoid syndrome develop with epidural steroid injec-
tion [70]. Diabetics can have a temporary elevation of
blood sugar levels up to 3–7 days. Patients with congestive
heart failure should be aware of possible ﬂuid retention due
to corticosteroids, although extremely uncommon [70]. No
studies show a relationship between epidural steroid
injection and osteoporosis or avascular necrosis [70].
Inadvertent intravascular injection of particulate cortico-
steroids can cause occlusion of small end arteries as
discussed above. All in all corticosteroid use in epidural
injections is safe when administered carefully.
Contrast media are usually non-ionic radiocontrast
agents with a more physiologic osmolality and less free
iodine. However, hypersensitive reactions are still possible
and would be evident within the ﬁrst few minutes after
injection. Anaphylactic reactions involve IgE-mediated
release of vasoactive substances after exposure to an
antigen to which there has been previous exposure and
sensitization [71, 72]. A true IgE type I hypersensitivity is
rare and only in severe cases [72]. Anaphylactoid reactions
occur through a non-immune mechanism. They are pseud-
oallergic reactions that are caused by the direct release of
histamineandothermediatorsfrom basophilsandmast cells
[71,72].Clinically,thesetworeactionsareindistinguishable
fromoneanother.Ifanallergyissuspectedthenpretreatment
withantihistaminesandcorticosteroidsshouldbeconsidered
[72, 73] or gadolinium should be used as an alternative [74].
These reactions are highly unusual in extravascular proce-
dures [75].
Conclusion
Complications from lumbar epidural injections are extre-
mely rare. Most if not all complications can be avoided by
careful technique with accurate needle placement, sterile
precautions, and a thorough understanding of the relevant
anatomy and contrast patterns on ﬂuoroscopic imaging.
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